Kellis, Manolis

Manolis Kellis is a researcher with a focus on genomics and the impact of the draft genome on publications, drug approvals, and understanding of disease. His work has been published in reputable scientific journals such as Nature. He co-authored an article discussing the 20th anniversary of the publication of the first draft of the human genome, exploring its effects on research into genetic roots of human disease, drug discovery, and understanding genes themselves.

Biography:  https://www.nature.com/articles/d41586-021-00314-6

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Insights into Alzheimer's Disease: Reelin, Neurofibrillary Tangles, and Emerging Biomarkers

New Insights into Alzheimer's Disease: Reelin, Neurofibrillary Tangles, and Emerging Biomarkers

Broke On: Monday, 29 July 2024 Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Recent research reveals its complex nature, focusing on pathological hallmarks - amyloid plaques and tau tangles. New findings suggest that maintaining adequate levels of Reelin protein might protect against amyloid plaque formation. Additionally, understanding cellular responses to neurofibrillary tangles could lead to potential therapeutic strategies. New biomarkers in cerebrospinal fluid offer hope for early detection and prediction.